Evidence map›Paper›PMID 30117805›Full record

ArticleeLife2018

A cell autonomous torsinA requirement for cholinergic neuron survival and motor control.

Samuel S Pappas, Jay Li, Tessa M LeWitt, Jeong-Ki Kim, Umrao R Monani, William T Dauer

Abstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Anticholinergic drugs for parkinsonism and other movement disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  4. A mismatch between striatal cholinergic pauses and dopaminergic reward prediction errors.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Pathophysiology of Dyt1-Science translational medicine · 2023
    Article
  7. Article
  8. DYT-Frontiers in neuroscience · 2023
    Review
  9. Article
  10. Review
  11. Collagen VI Regulates Motor Circuit Plasticity and Motor Performance by Cannabinoid Modulation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samuel S PappasDepartment of Neurology, University of Michigan, Ann Arbor, United States.ORCID http://orcid.org/0000-0002-6980-2058
Jay LiDepartment of Neurology, University of Michigan, Ann Arbor, United States.ORCID http://orcid.org/0000-0002-8146-4450
Tessa M LeWittDepartment of Neurology, University of Michigan, Ann Arbor, United States.
Jeong-Ki KimDepartment of Cell Biology, Columbia University Medical Center, New York, United States.ORCID http://orcid.org/0000-0003-0218-1215
Umrao R MonaniDepartment of Cell Biology, Columbia University Medical Center, New York, United States.
William T DauerDepartment of Neurology, University of Michigan, Ann Arbor, United States.ORCID http://orcid.org/0000-0003-1775-7504

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
The contributing effects of muscle, nerve and the NMJ to SMA pathologyR01NS057482 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONANI, UMRAO · 2008 to 2016
$3.1M
TorsinA function and dystonia-related dysfunction in developing and mature CNSR01NS077730 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAUER, WILLIAM T. · 2013 to 2017
$1.9M
Spinal muscular atrophy: Mechanisms and treatment strategies.R56NS104218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONANI, UMRAO · 2018 to 2018
$533k
The Spinal Muscular Atrophy NMJ phenotype: mechanisms and molecular mediatorsR21NS099921 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONANI, UMRAO · 2017 to 2018
$440k
NIGMS NIH HHS T32 GM007863NIH HHS R21NS099921NIH HHS R56NS104218NIH HHS RO1NS057482NINDS NIH HHS R01 NS057482NINDS NIH HHS R01 NS077730NINDS NIH HHS R21 NS099921NINDS NIH HHS R56 NS104218NINDS NIH HHS RO1NS077730
6 · The paper itself

Abstract

Cholinergic dysfunction is strongly implicated in dystonia pathophysiology. Previously (Pappas et al., 2015;4:e08352), we reported that Dlx5/6-Cre mediated forebrain deletion of the DYT1 dystonia protein torsinA (Dlx-CKO) causes abnormal twisting and selective degeneration of dorsal striatal cholinergic interneurons (ChI) (Pappas et al., 2015). A central question raised by that work is whether the ChI loss is cell autonomous or requires torsinA loss from neurons synaptically connected to ChIs. Here, we addressed this question by using ChAT-Cre mice to conditionally delete torsinA from cholinergic neurons ('ChAT-CKO'). ChAT-CKO mice phenocopy the Dlx-CKO phenotype of selective dorsal striatal ChI loss and identify an essential requirement for torsinA in brainstem and spinal cholinergic neurons. ChAT-CKO mice are tremulous, weak, and exhibit trunk twisting and postural abnormalities. These findings are the first to demonstrate a cell autonomous requirement for torsinA in specific populations of cholinergic neurons, strengthening the connection between torsinA, cholinergic dysfunction and dystonia pathophysiology.

Indexed as

AcetylcholineAnimalsCholine O-AcetyltransferaseCholinergic NeuronsCorpus StriatumDisease Models, AnimalDystoniaHumansMiceMolecular ChaperonesProsencephalonSynapsesAcetylcholineCholine O-AcetyltransferaseDyt1 protein, mouseMolecular ChaperonesTOR1A protein, humancholinergicdystoniaDYT1motor behaviormouseneurodegenerationneurosciencetorsinA

Identifiers

PMID30117805
PMCPMC6115190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.